You are here

Canada House Wellness Group Rebrands Patient Division as Canada House Clinics

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

TORONTO, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (CSE: CHV) (“Canada House”) is pleased to announce that after five years of servicing Veterans and the public as Marijuana for Trauma, our medical cannabis specialty clinics will be rebranded as Canada House ClinicsTM effective October 1st, 2018.

“This is part of our strategic plan to focus Canada House on the medical cannabis market with an integrated approach across our three divisions” says Chris Churchill-Smith, CEO of Canada House. “As a leading medicinal cannabis company that believes in helping renew lives through cannabinoid therapies, we are pleased to introduce our new look and branding for our clinics.”

Canada House Clinics operate across Canada and provide patients with education, support and access to medicinally prescribed cannabis.  The experienced and highly trained clinical staff provide ongoing support and monitoring of patients’ progress and results using advanced proprietary data analytics and tracking software.  Canada House Clinics currently has over 5,000 active patients, including over 2,000 Veterans and maintains a database of over 12,000 registrations.

“We are passionate about the opportunity to help all Canadians dealing with relevant common and complex medical conditions” says Alex Kroon, President of Canada House Clinics.  “Our new brand honors our veterans who know that the Canada House at the Kandahar Airfield in Afghanistan was an important refuge.   While we are proud of our success in helping people with PTSD, we already service Canadians from all walks of life, and we wanted a brand that demonstrates our commitment to quality healthcare to all Canadians”.

Canada House Wellness Group Inc.

Canada House is an experienced, integrated medical cannabis company providing patient-specific cannabinoid therapy products and services through its clinics and licensed producer. Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp.  For more information please visit http://www.canadahouse.ca. or www.sedar.com

For further information, please contact:

Boom Capital Markets
Steve Low
647-620-5101
steve@boomcapitalmarkets.com

Canada House Wellness Group Inc.
Chris Churchill-Smith, CEO
514-313-0102
chris.smith@canadahouse.ca

Cautionary Statement Regarding Forward Looking Information.  This press release contains forward-looking statements, including statements that relate to, among other things, the Company’s clinic, production and technology businesses, its future plans, the Company’s markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”, "possible", “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “objective” and “continue” (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, among other things, the regulations related to cannabis use under the Access to Cannabis for Medical Purposes Regulations and the act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts, passed by the Canadian Federal government, making cannabis legal for recreational use by October 17, 2018; Company liquidity and capital resources, including the availability of additional capital resources to fund its activities; level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key executives; and the ability to execute strategic plans. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company’s most recent annual and interim Management’s Discussion and Analysis under “Risk and Uncertainties” as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.”

Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Monday, September 24, 2018 - 07:00